Penicillamine or Distamine is indicated for the treatment of active R.A. and some other inflammatory arthropathies. It is normally used together with NSAIDs particularly in the early stages of treatment. Response to treatment cannot be expected before three months and may not occur until after six months of treatment.

CONTRA-INDICATIONS

DOSAGE

MONITORING

PRE TREATMENT SCREENING EACH MONITORING VISIT
  • Haemoglobin
  • Total white cell count
  • Neutrophil count
  • Platelet count
  • Urinalysis for protein and blood
  • Biochemical Profile
  • Haemoglobin
  • Total white cell count
  • Neutrophil count
  • Platelet count
  • Urinalysis for protein and blood

ADVERSE EVENTS

LABORATORY EVENTS VALUES ACTION
Leucopaenia < 3.5 x 10 9 /l STOP + seek advice
Neutropaenia < 2.5 x 10 9 /l STOP + seek advice
Thrombocytopaenia < 150 x 10 9 /l STOP + seek advice
Sequential falls in WBC or neutrophils > 10% on 3 occasions STOP + seek advice
Sequential falls in Platelets > 10% on 3 occasions STOP unless falls are from high level e.g. 600, 500, 400 x 10 3 which are response to treatment
Haematuria trace or + Continue Drug
Haematuria ++ or +++
  • STOP Drug
  • Check MSU
  • Consider other causes
  • Seek advice
Proteinuria trace or + Continue Drug
Proteinuria ++ or +++
  • STOP Drug
  • Check MSU
  • 24 hour urinary protein
  • Seek Advice

CLINICAL ADVERSE EVENTS MANAGEMENT
Rash Often non-specific erythematous, dry and itchy.
  • STOP drug if severe
  • Consider using 1% hydrocortisone and/or anti-histamines.
Metallic taste
  • Common in early weeks.STOP if severe.
  • Settles with time.
  • Stop if unacceptable.
Nausea
  • Reduce dose
  • Take with food.
  • STOP if unacceptable
Lupus syndrome
  • Rare and difficult to diagnose.
  • Stop if unacceptable
Dyspnoea/bronchiolitis STOP drug and Seek advice
Myaesthenic symptoms STOP drug and Seek advice

Source: Dr PR Crook, Consultant Rheumatologist.